This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...

Commissioner Marty Makary said he has no plans to change current policy to restrict access to the abortion pill mifepristone, ...

A federal judge in Texas handed Novo Nordisk (NVO) a big win late Thursday in its battle against cheaper versions of its ...

Except that the U.S. Food and Drug Administration (FDA) is now warning against going with option No.2, especially when it ...

Since the reversal of Roe v. Wade, the number of abortions is up because of telehealth and the free sharing of mifepristone ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

Hims & Hers (HIMS) stock in focus as a U.S. court denies injunction to continue making cheap versions of Novo Nordisk's (NVO) ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Sen. Josh Hawley said it is "extremely disappointing" that FDA Commissioner Dr. Marty Makary has "no plans" for abortion ...

A quick spray of medication might seem like an easy way to get thicker hair, but some people say one sold online has left ...